Xilio Therapeutics Inc at Citi Virtual Oncology Leadership Summit Transcript
Hello, and welcome to Day 3 of Citi's Oncology Leadership Conference. Delighted to have you with us again. I'm equally delighted to introduce our first speaker, Rene Russo, who is the CEO of Xilio. Now we're at broadchurch here at Citi's Oncology Conference with big hosting companies as large as Genetech Roche, Sanofi, GSK. And now we're down into the smaller names. But we think it's an interesting story and a very interesting technology. So we wanted to be early to highlight it to you.
So unlike the other sessions where many of you are very familiar with the underlying technology. What we've done is allocate some time for Rene, who's the CEO of Xilio to really provide some background of the company, and then we'll have time for Q&A afterwards, which I'll moderate. As always, if you do have a question you'd like me to ask Rene then please e-mail me, andrew.baumciti.com, and I'm more than happy to ask on your behalf. Anyway. With that, Rene, over to you, and thank you for joining us today.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |